Anderson Raymondinsider trades
In SEC Form 4 filings, Anderson Raymond is listed as Director of Monopar Therapeutics (MNPR). In the last 90 days, Anderson Raymond sold $351.8K of Monopar Therapeutics (MNPR) on the open market and bought none. All 3 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| MNPRMonopar Therapeutics | Director | 7 | Aug 28 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-08-28
Dashed line = amended filing (Form 4/A)
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| MNPRMonopar Therapeutics | Aug 25 | Aug 284/A | M | 1,402 | $30.00 | $42,060 | 6,775 | Yes | Form 4/A |
| MNPRMonopar Therapeutics | Aug 25 | Aug 284/A | M | 1,740 | $30.00 | $52,200 | 8,515 | Yes | Form 4/A |
| MNPRMonopar Therapeutics | Aug 25 | Aug 284/A | S | 694 | $110.04 | Sale −$76,368 | 7,821 | Yes | Form 4/A |
| MNPRMonopar Therapeutics | Aug 25 | Aug 284/A | S | 646 | $111.07 | Sale −$71,751 | 7,175 | Yes | Form 4/A |
| MNPRMonopar Therapeutics | Aug 25 | Aug 284/A | S | 1,802 | $113.05 | Sale −$203,716 | 5,373 | Yes | Form 4/A |
| MNPRMonopar Therapeutics | Aug 25 | Aug 284/A | M · derivative | 1,402 | $30.00 | $42,060 | 2,803 | Yes | Form 4/A |
| MNPRMonopar Therapeutics | Aug 25 | Aug 284/A | M · derivative | 1,740 | $30.00 | $52,200 | 3,480 | Yes | Form 4/A |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.